Evidence map›Paper›PMID 42562884›Full record

ArticleCell death and differentiation2026

Partial bypass of frataxin deficiency by ISCU M141I restores cytosolic and nuclear Fe-S cluster assembly.

Valentine Mosbach, Nunziata Maio, Lucie Hermet, Nadège Diedhiou, Adèle Hennick, Laure Dall'Agnol, Laurence Reutenauer, Lénaïc Marczak, Marie-Christine Birling, Aurélie Eisenmann and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Cell death and differentiation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Valentine MosbachUniversité de Lyon UMR5261, CNRS, INSERM U1315 Institut NeuroMyoGene-PGNM, Lyon, France.
Nunziata MaioMolecular Medicine Branch, 'Eunice Kennedy Shriver' National Institute of Child Health and Human Development, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-6225-6058
Lucie HermetUniversité de Lyon UMR5261, CNRS, INSERM U1315 Institut NeuroMyoGene-PGNM, Lyon, France.
Nadège DiedhiouInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC) INSERM U1258 CNRS UMR7104, Illkirch, France.
Adèle HennickUniversité de Lyon UMR5261, CNRS, INSERM U1315 Institut NeuroMyoGene-PGNM, Lyon, France.
Laure Dall'AgnolUniversité de Lyon UMR5261, CNRS, INSERM U1315 Institut NeuroMyoGene-PGNM, Lyon, France.
Laurence ReutenauerUniversité de Lyon UMR5261, CNRS, INSERM U1315 Institut NeuroMyoGene-PGNM, Lyon, France.
Lénaïc MarczakUniversité de Lyon UMR5261, CNRS, INSERM U1315 Institut NeuroMyoGene-PGNM, Lyon, France.
Marie-Christine BirlingCNRS, INSERM, CELPHEDIA, Institut Clinique de la Souris (ICS), Université de Strasbourg, Illkirch, France.ORCID http://orcid.org/0000-0002-3372-8108
Aurélie EisenmannInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC) INSERM U1258 CNRS UMR7104, Illkirch, France.
Alain MartelliInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC) INSERM U1258 CNRS UMR7104, Illkirch, France.
Hélène PuccioUniversité de Lyon UMR5261, CNRS, INSERM U1315 Institut NeuroMyoGene-PGNM, Lyon, France. helene.puccio@inserm.fr.ORCID http://orcid.org/0000-0003-4711-2248

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Iron-sulfur (Fe-S) clusters are essential cofactors required for the activity of numerous proteins involved in fundamental cellular processes, including DNA replication, metabolism and mitochondrial respiration. In eukaryotes, Fe-S cluster biogenesis is initiated in mitochondria by the ISC machinery, which assembles iron and sulfur, delivered by a cysteine desulfurase, onto the scaffold protein ISCU. Frataxin (FXN), a key regulator of this pathway, enhances Fe-S production by accelerating persulfide transfer to ISCU. FXN is essential in eukaryotes, and its loss results in a "petite" phenotype in yeast, senescence in dividing mammalian cells and embryonic lethality in mice. Interestingly, in yeast, a methionine to isoleucine substitution at position 141 of the scaffold protein Isu1 can bypass the requirement of FXN. To test whether this bypass mechanism is conserved in mammals, we introduced the equivalent M141I substitution into the endogenous Iscu gene in murine fibroblasts carrying a conditional Fxn allele using CRISPR-Cas9. We show that the ISCU M141I variant enables cell survival in the absence of FXN, preventing cell cycle arrest and decreasing baseline DNA damage. However, these FXN-null survivor clones exhibit slower proliferation, persistent mitochondrial dysfunction and defective mitochondrial Fe-S cluster proteins. In contrast, nuclear and cytosolic Fe-S proteins are preserved, as is cellular iron homeostasis. Importantly, the ISCU M141I variant delays, but does not fully rescue, embryonic lethality in Fxn-deficient mice. Altogether, our results reveal a previously unrecognized compartment-specific rescue of Fe-S cluster dependent processes by the ISCU M141I variant in mammalian cells, raising for the first time the possibility of compartmental regulation of Fe-S cluster biogenesis.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.